ArticleScientific reports2025
DB-SegNet: optimized framework for glaucoma detection and optic structure segmentation from retinal fundus images.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Lightweight Vision Transformer and Retinal Biomarker Fusion Framework for Early Glaucoma Detection: Toward Improved Clinical Screening.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glaucoma remains one of the primary causes of irreversible blindness, characterized by gradual damage to the optic nerve, which often goes undetected until advanced stages. Accurate and early diagnosis depends heavily on precise segmentation of the optic disc and optic cup in retinal fundus images, as this enables reliable calculation of the cup-to-disc ratio, a key biomarker for identifying and monitoring glaucoma. However, many current deep learning approaches struggle with generalization because of challenges such as variable image quality, blood vessel occlusion, and structural ambiguities, leading to reduced segmentation and classification accuracy. To address these issues, this study introduces DB-SegNet, an advanced diagnostic framework designed to enhance both segmentation accuracy and glaucoma detection. The proposed architecture builds upon SegNet by incorporating a Dilated Atrous Context Module (DACM) to capture multi-scale contextual features and a Bidirectional Feature Calibration Unit (BFCU) to refine boundary details. Feature space optimization is achieved through the Bitterling Fish Optimization (BFO) algorithm, while a Multi-Scale Attention Transformer (MSAT) is employed to model long-range spatial dependencies. In addition, Honey Badger Optimization (HBO) is applied for hyperparameter fine-tuning, ensuring stable and precise convergence. Evaluation on three widely used benchmark datasets such as Drishti-GS1, RIM-ONE, and ORIGA-Light demonstrates the effectiveness of the framework, yielding Dice coefficients of 99.2% for optic disc and 98.3% for optic cup segmentation, along with classification accuracies of 98.7% (RIM-ONE) and 99.1% (ORIGA-Light). These outcomes highlight the robustness of DB-SegNet in overcoming the limitations of existing techniques and underscore its potential as a clinically reliable tool for large-scale glaucoma screening and early intervention planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.